Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease

By Ryu J.K.   Kim S.U.   McLarnon J.G.  

Experimental Neurology, Vol. 183, Iss. 2, 2003-10 ,pp. : 700-704

Elsevier

Access to resources Recommend Favorite

Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABA A receptor changes

By Brickell K.L.   Nicholson L.F.B.   Waldvogel H.J.   Faull R.L.M.  

Journal of Chemical Neuroanatomy, Vol. 17, Iss. 2, 1999-10 ,pp. : 75-97

Elsevier

Access to resources Recommend Favorite

Neuroprotective Effects of NMDA and Group I Metabotropic Glutamate Receptor Antagonists Against Neurodegeneration Induced by Homocysteine in Rat Hippocampus: In Vivo Study

By Yeganeh F.   Nikbakht F.   Bahmanpour S.   Rastegar K.   Namavar R.  

Journal of Molecular Neuroscience, Vol. 50, Iss. 3, 2013-07 ,pp. : 551-557

Humana Press, Inc

Access to resources Recommend Favorite

Cyclosporin A and Bcl-2 do not inhibit quinolinic acid-induced striatal excitotoxicity in rodents

By Maciel E.N.   Kaminski Schierle G.S.   Hansson O.   Brundin P.   Castilho R.F.  

Experimental Neurology, Vol. 183, Iss. 2, 2003-10 ,pp. : 430-437

Elsevier

Access to resources Recommend Favorite

Reactive Astrocytes of the Quinolinic Acid-Lesioned Rat Striatum Express GFR 1 as Well as GDNF in Vivo

By Bresjanac M.   Antauer G.  

Experimental Neurology, Vol. 164, Iss. 1, 2000-07 ,pp. : 53-59

Elsevier

Access to resources Recommend Favorite